NASDAQ:BCRX   BioCryst Pharmaceuticals, Inc.
Favorite stock here. Fundamentals are outstanding. Excited for Q4 earnings and more importantly Q1. Future $100 stock in 5 years if execution on Bero and Factor D follow through.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。